Cancer vaccines entering Phase III clinical trials

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.8, Iss.2, 2003-11, pp. : 489-500

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives

Current Cancer Drug Targets, Vol. 11, Iss. 1, 2011-01 ,pp. : 85-102

Bentham Science Publishers

Access to resources Recommend Favorite

Quality-of-Life Assessment in Phase III Clinical Trials of Gemcitabine in Non-Small-Cell Lung Cancer

By Reynolds Jonathan K.

Drugs & Aging, Vol. 25, Iss. 11, 2008-01 ,pp. : 893-911

Adis International

Access to resources Recommend Favorite

Ethical Issues in Phase I Cancer Clinical Trials

By Peppercorn Jeffrey

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 4, 2006-01 ,pp. : 233-242

Adis International

Access to resources Recommend Favorite

Group-Sequential Methods for Adaptive Seamless Phase II/III Clinical Trials

By Stallard Nigel

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 787-801

Taylor & Francis Ltd

Access to resources Recommend Favorite

Understanding Site Performance Differences in Multinational Phase III Clinical Trials

By Glass Harold E. DiFrancesco Jeffrey J.

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 4, 2007-01 ,pp. : 279-286

Adis International

Access to resources Recommend Favorite